Hill June 21, 2024
A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found.
Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the severity of sleep apnea, a disorder that causes breathing to be interrupted, among other measures in patients who had obesity and took the medication for a year.
The study, published Friday in the New England Journal of Medicine, was conducted in two controlled trials involving adults with moderate to severe obstructive sleep apnea and obesity. The study found that tirzepatide reduced the apnea-hypopnea index, body weight, blood pressure and improved sleep, among other things.
Patients who took the drug had their number of sleep apnea...
Today's Sponsors
Today's Sponsor